What are the side effects of Propafenone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propafenone Side Effects

Propafenone has numerous side effects affecting multiple body systems, with the most common being gastrointestinal, cardiovascular, and central nervous system effects, occurring in approximately 20% of patients treated with this medication. 1

Common Side Effects

Gastrointestinal Effects

  • Unusual taste (14% of patients) 1
  • Nausea and/or vomiting (11% of patients) 1
  • Constipation (8% of patients) 1
  • Diarrhea (2% of patients) 1
  • Anorexia (2% of patients) 1

Cardiovascular Effects

  • Dizziness (9% of patients) 1
  • Wide complex tachycardia (2% of patients) 1
  • Congestive heart failure (2% of patients) 1
  • Bradycardia (2% of patients) 1
  • Palpitations (2% of patients) 1
  • First-degree AV block (up to 5% in ventricular arrhythmia patients) 1
  • Intraventricular conduction delay (up to 4% in ventricular arrhythmia patients) 1
  • Proarrhythmia (1-5% depending on dose) 1

Central Nervous System Effects

  • Headache (6% of patients) 1
  • Fatigue (6% of patients) 1
  • Blurred vision (3% of patients) 1
  • Weakness (3% of patients) 1
  • Tremor (2% of patients) 1
  • Ataxia (2% of patients) 1

Dose-Related Side Effects

The incidence of certain side effects increases with higher doses of propafenone 1:

  • Dizziness: 4% at 450 mg/day, increasing to 11% at ≥900 mg/day
  • Nausea/vomiting: 2% at 450 mg/day, increasing to 9% at ≥900 mg/day
  • Unusual taste: 3% at 450 mg/day, increasing to 6% at ≥900 mg/day
  • Constipation: 2% at 450 mg/day, increasing to 5% at ≥900 mg/day

Serious Cardiovascular Side Effects

Propafenone can cause serious cardiovascular side effects that require careful monitoring 2, 3:

  • Ventricular tachycardia and ventricular fibrillation 3
  • QRS prolongation (an increase >25% from baseline indicates potential proarrhythmic risk) 3
  • Rapid atrial flutter with 1:1 AV conduction 2
  • Worsening of heart failure 2

Contraindications and Special Precautions

Propafenone should be avoided in certain patient populations 2, 3:

  • Patients with heart failure or reduced left ventricular ejection fraction 3
  • Patients with structural heart disease 2
  • Patients with severe obstructive lung disease 2
  • Patients with sinus or AV conduction disease (in absence of pacemaker) 2
  • Patients with cardiogenic shock 2
  • Patients with hypotension 2
  • Patients with Brugada syndrome 2

Less Common but Serious Side Effects

Propafenone can occasionally cause these serious adverse effects 1:

  • Hepatic abnormalities including hepatitis and cholestasis (0.1-0.2%) 1
  • Hematologic effects including agranulocytosis, anemia, thrombocytopenia 1
  • Lupus-like syndrome (positive ANA in 0.7% of patients) 1
  • Neurological effects including seizures (0.3%), confusion, memory loss 1

Monitoring Recommendations

To minimize risks associated with propafenone therapy 2, 3:

  • Regular ECG monitoring is essential during initiation and dose adjustments 3
  • Monitor for QRS prolongation 3
  • Use with caution in patients with mild structural heart abnormalities 3
  • Be aware of drug interactions, particularly with digoxin, warfarin, metoprolol, and propranolol 4

Discontinuation Rates

About 15% of patients discontinue propafenone due to adverse effects 5. The incidence of side effects is related to dose and age >65 years, with cardiovascular toxicity occurring more frequently in patients with heart disease (20% vs 13% in those without heart disease) 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propafenone Use in Structural Heart Disease and Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of propafenone.

Clinical pharmacokinetics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.